Vivos Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Vivos Therapeutics, Inc. (VVOS) had Operating Lease, Weighted Average Discount Rate, Percent of 27.20% as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-04-15
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 27.20%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.40%.
- 2024-06-30: Operating Lease, Weighted Average Discount Rate, Percent 8.40%.
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 8.40%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 27.20% 10-K · filed 2026-04-15 |
| 2024-12-31 | 8.40% 10-K · filed 2026-04-15 |
| 2024-06-30 | 8.40% 10-Q · filed 2024-08-14 |
| 2024-03-31 | 8.40% 10-Q · filed 2024-05-14 |
| 2023-12-31 | 8.30% 10-K · filed 2025-03-31 |
| 2023-09-30 | 8.20% 10-Q · filed 2023-11-14 |
| 2023-06-30 | 8.30% 10-Q · filed 2023-08-16 |
| 2023-03-31 | 8.30% 10-Q · filed 2023-06-08 |
| 2022-12-31 | 8.30% 10-K/A · filed 2024-07-30 |
| 2022-09-30 | 8.00% 10-Q · filed 2022-12-20 |
| 2022-06-30 | 8.00% 10-Q · filed 2022-12-20 |
| 2022-03-31 | 6.90% 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |